Clinical Trials & Research
Search Clinical Trials
|Title||Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy|
|Description||The purpose of this trial is to study chemotherapy and pelvic radiation therapy to see how well they work when given with or without additional chemotherapy in treating patients with high-risk early-stage cervical cancer after radical hysterectomy.|
Drugs used in chemotherapy, such as cisplatin, paclitaxel, and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.
Radiation therapy uses high-energy x-rays to kill tumor cells. It is not yet known whether chemotherapy and radiation therapy are more effective when given with or without additional chemotherapy in treating cervical cancer.
|Eligibility Criteria||To be eligible for this study, patients must meet several criteria, including but not limited to the following:|
* Patient must be 18 Years and older
* Patient must have histologically confirmed squamous, adenosquamous, or adenocarcinoma of the cervix with any/all high-risk after surgery.
* Patient must have undergone radical hysterectomy (open, laparoscopically, or robotic) and staging within the past 70 days.
|Principal Investigator||Mark Einstein, MD|
|Contact Name||Loraine Centrilla, RN|
|Contact Email||lcentril@montefiore .org|
|Current Trial Type||Interventional|
|Montefiore Clinical Trial||No|
|CHAM Clinical Trial||No|